The number of cancer survivors in the United States is increasing due to an aging population, improved early detection, and treatment. The American Cancer Society and National Cancer Institute estimated that 14.5 million Americans had a history of cancer as of January 1, 2014, with this number expected to rise to nearly 19 million by 2024. The most common cancers among males are prostate (43%), colorectal (9%), and melanoma (8%), while among females, they are breast (41%), uterine corpus (8%), and colon and rectum (8%). Age distribution varies by cancer type, with prostate cancer survivors predominantly over 70 years old, while melanoma survivors are younger. Cancer survivors face long-term treatment-related side effects, including lymphedema, chronic pain, and fertility issues. Treatment patterns vary by cancer type and stage, with surgery, chemotherapy, and radiation therapy being common. Survival rates have improved over time, particularly for breast and colorectal cancers. For example, the 5-year relative survival rate for breast cancer increased from 74.8% in 1975 to 90.3% in 2003-2009. For prostate cancer, survival rates are very high, with 99.7% for all stages combined. Treatment for childhood cancers has improved significantly, with survival rates for children aged 0-14 years reaching 97.5% for retinoblastoma. For adolescents, survival rates are similar to those for children. Long-term side effects of cancer treatment, such as cognitive impairments, chronic fatigue, and secondary cancers, are common. The article also discusses the importance of survivorship care, including psychological support and long-term follow-up. Overall, cancer survivorship is a complex area requiring multidisciplinary care and ongoing research.The number of cancer survivors in the United States is increasing due to an aging population, improved early detection, and treatment. The American Cancer Society and National Cancer Institute estimated that 14.5 million Americans had a history of cancer as of January 1, 2014, with this number expected to rise to nearly 19 million by 2024. The most common cancers among males are prostate (43%), colorectal (9%), and melanoma (8%), while among females, they are breast (41%), uterine corpus (8%), and colon and rectum (8%). Age distribution varies by cancer type, with prostate cancer survivors predominantly over 70 years old, while melanoma survivors are younger. Cancer survivors face long-term treatment-related side effects, including lymphedema, chronic pain, and fertility issues. Treatment patterns vary by cancer type and stage, with surgery, chemotherapy, and radiation therapy being common. Survival rates have improved over time, particularly for breast and colorectal cancers. For example, the 5-year relative survival rate for breast cancer increased from 74.8% in 1975 to 90.3% in 2003-2009. For prostate cancer, survival rates are very high, with 99.7% for all stages combined. Treatment for childhood cancers has improved significantly, with survival rates for children aged 0-14 years reaching 97.5% for retinoblastoma. For adolescents, survival rates are similar to those for children. Long-term side effects of cancer treatment, such as cognitive impairments, chronic fatigue, and secondary cancers, are common. The article also discusses the importance of survivorship care, including psychological support and long-term follow-up. Overall, cancer survivorship is a complex area requiring multidisciplinary care and ongoing research.